http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104721151-B

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-489
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-898
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04
filingDate 2015-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2018-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2018-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-104721151-B
titleOfInvention A kind of segmented intestine targeted multiple coatings pellet and preparation method thereof with drug multicomponent synchronous release function
abstract The present invention relates to technical field of pharmaceuticals, and in particular to a kind of segmented intestine targeted multiple coatings pellet and preparation method thereof with drug multicomponent synchronous release function.A kind of segmented intestine targeted multiple coatings pellet with drug multicomponent synchronous release function, it is made of the component of following weight percent:Carry pill core:Total alkaloid of sophora alopecuroide 25% ~ 45.5%, microcrystalline cellulose 24% ~ 50%, bletilla polysaccharide 20% ~ 36%, CMC Na aqueous solutions 5% ~ 10%;Internal layer coating;Middle level is coated;Outer layer coating.The segmented intestine targeted multiple coatings pellet with drug multicomponent synchronous release function, release rate is minimum when by epimere gastrointestinal tract, have the advantages that segmented intestine targeted make good use of, and can stability contorting in therapeutic window range, and it carries a variety of active ingredients in the total alkaloid of sophora alopecuroide in pill core and can synchronize and disengage, therefore, there is good therapeutic effect.
priorityDate 2015-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154496880
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID3885
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID200492
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559553
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410578228
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360545
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID3885
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID618688
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8195
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID3888
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416041939
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415860638
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID3888
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID200492
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419497688
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91466
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415816935
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322703
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID162147
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419594533
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID165549
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6506
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419530952
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID114850
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID115269
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415858568
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411174055
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4329331

Total number of triples: 44.